1. Home
  2. PCVX vs AFRM Comparison

PCVX vs AFRM Comparison

Compare PCVX & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • AFRM
  • Stock Information
  • Founded
  • PCVX 2013
  • AFRM 2012
  • Country
  • PCVX United States
  • AFRM United States
  • Employees
  • PCVX N/A
  • AFRM N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • AFRM Business Services
  • Sector
  • PCVX Health Care
  • AFRM Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • AFRM Nasdaq
  • Market Cap
  • PCVX 4.4B
  • AFRM 19.1B
  • IPO Year
  • PCVX 2020
  • AFRM 2021
  • Fundamental
  • Price
  • PCVX $32.94
  • AFRM $68.83
  • Analyst Decision
  • PCVX Strong Buy
  • AFRM Buy
  • Analyst Count
  • PCVX 10
  • AFRM 22
  • Target Price
  • PCVX $136.50
  • AFRM $65.89
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • AFRM 5.9M
  • Earning Date
  • PCVX 08-05-2025
  • AFRM 08-27-2025
  • Dividend Yield
  • PCVX N/A
  • AFRM N/A
  • EPS Growth
  • PCVX N/A
  • AFRM N/A
  • EPS
  • PCVX N/A
  • AFRM N/A
  • Revenue
  • PCVX N/A
  • AFRM $3,007,180,000.00
  • Revenue This Year
  • PCVX N/A
  • AFRM $39.73
  • Revenue Next Year
  • PCVX N/A
  • AFRM $22.49
  • P/E Ratio
  • PCVX N/A
  • AFRM N/A
  • Revenue Growth
  • PCVX N/A
  • AFRM 42.55
  • 52 Week Low
  • PCVX $27.66
  • AFRM $22.25
  • 52 Week High
  • PCVX $121.06
  • AFRM $82.53
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 46.08
  • AFRM 72.12
  • Support Level
  • PCVX $32.06
  • AFRM $59.68
  • Resistance Level
  • PCVX $33.81
  • AFRM $62.88
  • Average True Range (ATR)
  • PCVX 1.23
  • AFRM 2.34
  • MACD
  • PCVX -0.12
  • AFRM 0.55
  • Stochastic Oscillator
  • PCVX 19.86
  • AFRM 88.65

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About AFRM Affirm Holdings Inc.

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

Share on Social Networks: